ALS Ltd. (CPBLF) was upgraded to a Buy Rating at UBS
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 21 2024
0mins
Should l Buy ?
Source: Business Insider
Analyst Rating and Financial Performance: ALS Ltd. received a Buy rating from UBS with a price target of A$17.00, despite reporting a quarterly revenue of $25.2 billion and a GAAP net loss of $346 million, compared to last year's profit of $1.12 billion.
Insider Activity and Company Overview: Positive insider sentiment is noted as six insiders have increased their share purchases, while ALS Ltd. provides technical services across various sectors including Life Sciences and Industrial, operating since 1863 and headquartered in Brisbane, Australia.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
